Medical Countermeasures | Global Biodefense

Menu

Latest stories

Bavarian Nordic Announces Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine

MRI of part of brain

Radiation Poisoning Countermeasure May Also Protect Against Potential MRI Contrast Agent Toxicity

More on pathogens and preparedness

BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract

by Global Biodefense September 26, 2019, 8:58 am
FDA Approves Jynneos to Prevent Smallpox and Monkeypox

by Global Biodefense September 24, 2019, 8:00 pm
Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core
20 Years of the Strategic National Stockpile: Response History Timeline

by Global Biodefense August 25, 2019, 9:47 am
Popular

Project BioShield: Building a Better Medical Countermeasure Pipeline

by Global Biodefense August 5, 2019, 5:00 am
Silverlon Wound Dressings Cleared by FDA for Injuries Caused by Mustard Gas

by Global Biodefense August 2, 2019, 5:00 am
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine
Popular

Study Shows Virulence of B. pseudomallei Strain in Aerosol Model

by Global Biodefense July 23, 2019, 9:00 am
Modeling the Complexities of the Gut for Biodefense Applications

by Global Biodefense July 16, 2019, 11:50 am
In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures

by Global Biodefense June 18, 2019, 10:03 am
USAID Seeks Innovations in Malaria Vaccine Development
Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

by Global Biodefense June 11, 2019, 5:00 am

Congratulations. You've reached the end of the internet.

Back to Top